Cargando…

Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer

BACKGROUND: Silibinin, as a chemopreventive agent, has shown anti-cancer efficacy against different types of cancers. In the present study, we investigated the anti-cancer activities of silibinin on CT26 mouse colon cell line. METHODS: CT26 cells were treated with different concentrations of silibin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sameri, Saba, Mohammadi, Chiman, Mehrabani, Mehrnaz, Najafi, Rezvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168007/ https://www.ncbi.nlm.nih.gov/pubmed/34059044 http://dx.doi.org/10.1186/s12906-021-03330-1

Ejemplares similares

SEMA4D Knockdown Attenuates β-Catenin-Dependent Tumor Progression in Colorectal Cancer
por: Rezaeepoor, Mahsa, et al.
Publicado: (2021)

DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021)

Is angiogenesis a hallmark of prostate cancer?
por: Taverna, Gianluigi, et al.
Publicado: (2013)

Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy
por: Jafari, Sevda, et al.
Publicado: (2023)

Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy
por: Raina, Komal, et al.
Publicado: (2016)

Genetic and biological hallmarks of colorectal cancer
por: Li, Jiexi, et al.
Publicado: (2021)

Silibinin and non-melanoma skin cancers
por: Prasad, Ram Raj, et al.
Publicado: (2020)

Proliferation and tissue remodeling in cancer: the hallmarks revisited
por: Markert, E K, et al.
Publicado: (2012)

The hallmarks of ovarian cancer: proliferation and cell growth
por: López-Reig, Raquel, et al.
Publicado: (2020)

Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer
por: Wagner, Nicole, et al.
Publicado: (2022)

Editorial: Hallmark of cancer: Resisting cell death
por: Zhu, Yichao, et al.
Publicado: (2022)

The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
por: De Palma, Fatima Domenica Elisa, et al.
Publicado: (2019)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation
por: Heredia-Soto, V., et al.
Publicado: (2020)

Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells
por: Jackson, Kiren, et al.
Publicado: (2020)

Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP
por: Dan, Weichao, et al.
Publicado: (2022)

MicroRNA 452 Regulates Cell Proliferation, Cell Migration, and Angiogenesis in Colorectal Cancer by Suppressing VEGFA Expression
por: Mo, Ji Su, et al.
Publicado: (2019)

HypoxaMIRs: Key Regulators of Hallmarks of Colorectal Cancer
por: Coronel-Hernández, Jossimar, et al.
Publicado: (2022)

Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation
por: McClure, Janela, et al.
Publicado: (2012)

Curcumin, but not its degradation products, in combination with silibinin is primarily responsible for the inhibition of colon cancer cell proliferation
por: Sayyed, Alhan, et al.
Publicado: (2022)

Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer
por: Hoskin, Ashley J., et al.
Publicado: (2023)

MicroRNA-934 facilitates cell proliferation, migration, invasion and angiogenesis in colorectal cancer by targeting B-cell translocation gene 2
por: Li, Bo, et al.
Publicado: (2021)

Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer
por: Salita, Timothy, et al.
Publicado: (2022)

Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model
por: Yang, Cheng-Yu, et al.
Publicado: (2020)

Correction: Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation
por: McClure, Janela, et al.
Publicado: (2012)

Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer
por: Yang, Shuyan, et al.
Publicado: (2022)

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
por: Molavi, Ommoleila, et al.
Publicado: (2016)

Lung Cancer Management with Silibinin: A Historical and Translational Perspective
por: Verdura, Sara, et al.
Publicado: (2021)

Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses
por: Bredholt, Geir, et al.
Publicado: (2015)

Hallmarks of glycosylation in cancer
por: Munkley, Jennifer, et al.
Publicado: (2016)

Melatonin and Cancer Hallmarks
por: Talib, Wamidh H.
Publicado: (2018)

The microbiome and the hallmarks of cancer
por: Fulbright, Laura E., et al.
Publicado: (2017)

The Hallmarks of Flavonoids in Cancer
por: Ponte, Luis Gustavo Saboia, et al.
Publicado: (2021)

Heparanase and the hallmarks of cancer
por: Jayatilleke, Krishnath M., et al.
Publicado: (2020)

An Update to Hallmarks of Cancer
por: Ravi, Swapna, et al.
Publicado: (2022)

Proliferation and In Vitro Wound Healing Effects of the Microniosomes Containing Narcissus tazetta L. Bulb Extract on Primary Human Fibroblasts (HDFs)
por: Rameshk, Maryam, et al.
Publicado: (2018)

An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer
por: Samadi, Pouria, et al.
Publicado: (2022)

SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis
por: Liu, Yang, et al.
Publicado: (2020)

Cadherin-12 contributes to tumorigenicity in colorectal cancer by promoting migration, invasion, adhersion and angiogenesis
por: Zhao, Jingkun, et al.
Publicado: (2013)

Overexpression of ELL-associated factor 2 suppresses invasion, migration, and angiogenesis in colorectal cancer
por: Feng, Ming-Liang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qtgbrln4h6s9khnhgnl53taked